Review ArticleIndian Journal of Pharmacy PracticeVol. 19 | Issue 2 | pp. 167–171Open access
Precision Medicine in Pharmacy Practice: Advancements and Implications
- 1*
- 1 Department of Clinical Pharmacy, Believers Church Medical College Hospital, Thiruvalla, Kerala, INDIA.
Published in Indian Journal of Pharmacy Practice
Correspondence: Athul. H
Department of Clinical Pharmacy, Believers Church Medical College Hospital, Thiruvalla, Kerala, INDIA.
Email: athulhari10102000@gmail.com
- Received:
- Jul 24, 2025
- Accepted:
- Nov 3, 2025
- DOI:
- 10.5530/ijopp.20260548
How to cite
H, A. Precision Medicine in Pharmacy Practice: Advancements and Implications. Indian Journal of Pharmacy Practice, 19(2), 167–171. https://doi.org/10.5530/ijopp.20260548
Abstract
Precision medicine, which is often referred to as personalised medicine, is a cutting-edge approach to healthcare that aims to customise medical treatments for individual patients according to their lifestyle, genetic composition, and environmental circumstances. Precision medicine, which emphasises pharmacogenomics, individualised medication regimens, and the use of biomarkers to improve patient care, has completely changed the way pharmacists approach drug therapy in pharmacy practice. The function of precision medicine in pharmacy practice is covered in this review article, which also highlights significant developments, difficulties, and potential paths forward.
Keywords
Subject
Article metadata
| Title | Precision Medicine in Pharmacy Practice: Advancements and Implications |
|---|---|
| Authors | Athul. H |
| Affiliations | Department of Clinical Pharmacy, Believers Church Medical College Hospital, Thiruvalla, Kerala, INDIA. |
| Corresponding author | athulhari10102000@gmail.com |
| Journal | Indian Journal of Pharmacy Practice |
| Volume / Issue | Vol. 19, Issue 2 |
Also in this issue
- EGFR Inhibitors: Current Status, Resistance Mechanisms, and Market Insightpp. 139–150
- Community Pharmacists and Their Role in Non-Communicable Disease (NCD) Management: A Critical Review of Global and Indian Evidencepp. 151–158
- Reviving the Remedy: Global Action against Antimicrobial Resistance through Stewardshippp. 159–166
- Recent Clinical Trials and Industry Updates on EGFR Inhibitors (2024-2025)pp. 172–178
- Human Metapneumovirus in Focus: Emerging Insights into a Silent Respiratory Threatpp. 179–185